If you need more lookups,
subscriptions start at $34 USD/month.
Andy Parker Location
France
Andy Parker Work
2019 -now President and Chief Executive Officer @
2016 -now Board Member @ Eclosion2 SA
2016 -2020 Scientific Advisor @ Foundation Eclosion
2016 -2019 Board Member @ PEPTIDE THERAPEUTICS FOUNDATION
2016 -2019 CSO and EVP, Head of Research and External Innovation @
2014 -2016 General Partner and Scientific Director @ Eclosion2
2011 -2013 Vice President, Head of Exploratory Projects @
2008 -2010 Vice President of Research @ Opsona Therapeutics
1998 -2008 Associate Director, Respiratory and Inflammation Research @
1995 -1997 Team Leader @
Andy Parker Education
University of Warwick - Warwick Business School
MBA
2011-2013
The Johns Hopkins University School of Medicine
Post Doctoral Fellow (Molecular & Cell Biology)
1992-1996
National Institute for Medical Research
Ph.D. (Molecular & Cell Biology)
1988-1991
University of Surrey
B.Sc (Microbiology)
1984-1988
Andy Parker Skills
Drug Discovery
Clinical Development
Pharmaceutical Industry
Lifesciences
Biotechnology
Drug Development
Technology Transfer
Pharmacology
Cell
In Vitro
Biochemistry
Oncology
Cancer
Medicinal Chemistry
CRO
Life Sciences
R&D
Clinical Trials
Training
Healthcare
Team Leadership
Project Management
Business Strategy
Research
Andy Parker Summary
Andy Parker, based in France, is currently a President and Chief Executive Officer at Step Pharma. Andy Parker brings experience from previous roles at Eclosion2 SA, Foundation Eclosion, PEPTIDE THERAPEUTICS FOUNDATION and Zealand Pharma A/S. Andy Parker holds a 2011 - 2013 MBA @ University of Warwick - Warwick Business School. With a robust skill set that includes Drug Discovery, Clinical Development, Pharmaceutical Industry, Lifesciences, Biotechnology and more. Andy Parker has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Andy Parker?
Find contact details for 700 million professionals.